THURSDAY, Aug. 27, 2026 — The U.S. Food and Drug Administration (FDA) has approved the first drug shown to substantially extend the lives of people with advanced pancreatic cancer, nearly doubling survival time in a key clinical trial.
The…
Blog
Leave a Reply